Melanotan II is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2026-06-17. Where a claim depends on a specific study, the study is described rather than over-claimed.
The peptide was developed during the 1980s by researchers investigating melanocortin signalling and skin pigmentation pathways. Early work focused on analogues of alpha-melanocyte-stimulating hormone that would resist enzymatic breakdown more effectively than the parent molecule. Melanotan-2 emerged from that programme as a shortened, cyclised variant. Reports describing its synthesis and receptor activity later appeared in the scientific literature. Commercial availability grew through unregulated channels rather than through pharmaceutical approval.
Structurally, Melanotan-2 retains the core recognition motif of alpha-melanocyte-stimulating hormone while adding a lactam bridge that links two side chains and constrains the molecule into a ring. This modification lowers susceptibility to enzymatic degradation. The compound acts as an agonist at melanocortin receptors, particularly subtypes associated with melanin production. Because the same receptor family influences several physiological processes, researchers note that its activity is not confined to pigmentation alone. Receptor selectivity continues to be examined in published studies.
Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation signalling. Its sequence incorporates modified residues that increase potency and extend biological activity relative to the native hormone. The compound binds receptors of the melanocortin family and is examined mainly in laboratory research. It does not occur naturally and exists only as a manufactured chemical entity produced by solid-phase synthesis.
Outside regulated medicine, melanotan II circulates through online vendors as a research chemical, often marketed for tanning. Products sold this way vary widely in purity, concentration, and labeling accuracy, and independent testing has documented discrepancies. Published reports describe both pigment effects and adverse reactions, including nausea, flushing, and darkening of existing moles. Long-term safety data are sparse, and no large controlled trial has established a risk profile. Questions about cumulative effects on melanocytes remain unresolved in the literature.
Melanotan II is a synthetic peptide analog modeled on alpha-melanocyte-stimulating hormone, a naturally occurring signaling peptide involved in pigmentation. Its structure is a cyclic heptapeptide containing two non-natural substitutions, norleucine at position four and D-phenylalanine at position seven. These modifications resist enzymatic breakdown and extend the molecule's activity relative to the native hormone. The compound binds melanocortin receptors and is studied mainly as a pharmacological tool rather than a therapeutic product. It has never received approval as a medicine in any major jurisdiction.
The compound was developed in the late 1980s and 1990s by academic researchers investigating photoprotection. The rationale held that stimulating melanin production might reduce ultraviolet damage to skin and lower skin cancer risk. Early work examined receptor binding, pigment response, and short-term tolerability in small studies. That program did not produce an approved drug, and formal development stalled after early-phase trials. Whether induced pigmentation confers meaningful photoprotection remains an open question.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C50H69N15O9 | Synthetic cyclic heptapeptide |
| Molecular mass | Approximately 1024 g/mol | Depends on counter-ion content |
| Appearance | White to off-white powder | Commonly supplied as a lyophilised solid |
| Solubility | Freely soluble in water | Also dissolves in common aqueous buffers |
| Typical storage | -20 degrees Celsius, desiccated | Protect from light and repeated freeze-thaw |
The peptide acts as a non-selective agonist at melanocortin receptors, showing affinity for MC1R, MC3R, MC4R and MC5R. Activation of MC1R on melanocytes drives the conversion of tyrosine into melanin and shifts production toward the darker eumelanin form. MC4R signalling in the central nervous system is linked to appetite and energy balance, which helps explain why reduced food intake appeared in early human studies. Effects on MC4R and on vascular tone also account for the erectile responses recorded as unexpected findings in those same trials.
Melanotan-2 is frequently confused with afamelanotide, a linear analogue authorised in the European Union for erythropoietic protoporphyria. The two compounds differ in chain length, ring structure and receptor selectivity, so findings for one cannot be transferred directly to the other. Published controlled human data on melanotan-2 remain sparse, and much of what circulates online derives from small studies or unpublished reports. Questions about effect size, dose-response behaviour and long-term safety therefore remain unresolved.
Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone, the naturally occurring peptide involved in pigmentation signalling. Its sequence is conventionally written as Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, with a lactam bridge joining the aspartate side chain to the lysine side chain. The empirical formula is C50H69N15O9 and the monoisotopic mass lies near 1023.5 daltons. N-terminal acetylation and the D-configured phenylalanine both increase resistance to enzymatic breakdown compared with the parent hormone.
Pharmacologically, melanotan-2 behaves as a non-selective agonist across the melanocortin receptor family. Binding at MC1R on dermal melanocytes promotes eumelanin synthesis, which underlies the tanning response described in early human work. Activity at the centrally expressed MC4R receptor is associated with reported effects on appetite and erectile function. Because the peptide does not discriminate strongly among receptor subtypes, attributing any single observed effect to one receptor pathway is generally not possible without selective antagonists or receptor knockout models.
Receptor binding at MC1R on melanocytes raises intracellular cyclic AMP and increases expression of tyrosinase and related enzymes. The downstream result is greater synthesis of eumelanin, the dark pigment, without ultraviolet exposure acting as the trigger. The compound is not selective, however, and also engages MC3R, MC4R and MC5R, which are expressed in the central nervous system and elsewhere. That lack of selectivity is the explanation usually offered for effects reported outside pigmentation, including appetite suppression and nausea. Selectivity remains a central theme in comparative studies of related peptides.
Human data remain limited and mostly short-term. Reports describe small trials and observational accounts rather than large controlled studies, so questions about dose-response relationships and long-term effects on melanocytes stay open. Whether repeated exposure alters naevus behaviour is not settled in the published record. Researchers also note that self-administered use outside clinical settings makes actual exposure difficult to quantify. Statements about efficacy and safety should therefore be read as preliminary rather than established.
Melanotan II is a synthetic cyclic heptapeptide that acts as an agonist at melanocortin receptors. It was designed as a structural analogue of alpha-melanocyte-stimulating hormone, the endogenous peptide involved in pigment production. The analogue carries a lactam bridge that constrains the ring and slows enzymatic breakdown relative to the native hormone. In research literature it appears under several abbreviations, and naming conventions are not fully standardized. Published descriptions usually place it within the broader melanocortin agonist family.
Member American Academy of Arts & Sciences (2025) Member, The World Academy of Science (2025) Founders Award, Controlled Release Society (2025) Distinguished Scientist Award, American Association of Pharmaceutical Scientists (2024) Doing a World of Good Medal (2023) BIOS- Top 50 Lifescience Entrepreneur List (2022) Kydonieus Award, Controlled Release Society (2020) Clemson Award, Society for Biomaterials (2017) Member, National Academy of Medicine (NAM) (2016) Fellow, Biomedical Engineering Society (BMES) (2015) Fellow, American Association of Pharmaceutical Scientists (AAPS) (2015) Fellow, Controlled Release Society (CRS) (2015) Andreas Acrivos Award for Professional Progress, American Institute of Chemical Engineers (AIChE) (2015) Member, National Academy of Engineering (NAE) (2015) Fellow, National Academy of Inventors (NAI) (2013) Fellow, American Association for the Advancement of Science (AAAS) (2012) Fellow, American Institute for Medical and Biological Engineering (AIMBE) (2010) Controlled Release Society’s Young Scientist Award (2008) American Institute of Chemical Engineers Allan P. Colburn award (2005) Selection by MIT's Technology Review Magazine as one of the world's top Innovators Under 35 (1999)
=== Regulation of supraoptic neurons === Vasopressin (antidiuretic hormone, ADH) is released in response to solute concentration in the blood, decreased blood volume, or blood pressure. Some other inputs come from the brainstem, including from some of the noradrenergic neurons of the nucleus of the solitary tract and the ventrolateral medulla. However, many of the direct inputs to the supraoptic nucleus come from neurons just outside the nucleus (the "perinuclear zone"). Of the afferent inputs to the supraoptic nucleus, most contain either the inhibitory neurotransmitter GABA or the excitatory neurotransmitter glutamate, but these transmitters often co-exist with various peptides. Other afferent neurotransmitters include noradrenaline (from the brainstem), dopamine, serotonin, and acetylcholine.
== History == In 1920, a conference held during the 1st World Scout Jamboree at Olympia, London agreed to create a Boy Scouts international bureau. An office was established at 25 Buckingham Palace Road, London and The Boy Scouts Association of the United Kingdom International Commissioner, Hubert S. Martin, was appointed honorary director. The bureau's principal task was to co-ordinate discussions and prepare a second international conference in Paris in 1922. At the 1922 Paris conference, The International Conference of the Boy Scout Movement and its committee were constituted and took over the bureau in London. In 1961, the organisation's conference reconstituted the organisation under the name World Organization of the Scout Movement (WOSM). Its International Conference of the Boy Scout Movement became WOSM's World Scout Conference ("conference"), its Boy Scouts International Committee became WOSM's World Scout Committee ("committee") and its Boy Scouts International Bureau became WOSM's World Scout Bureau ("bureau").
In 1990, Maroon et al. published the first microsurgical approach to far lateral disc herniations in the lumbar spine and in 2007, they published the case of Golfer's Stroke from Vertebral Artery Dissection. Further groundbreaking publications include the use of fish oil as an anti-inflammatory and alternative to nonsteroidal drugs for discogenic pain (2006); a unifying, immunoexcitotoxicity hypothesis for chronic traumatic encephalopathy (2011); and the possible use of a restricted calorie ketogenic diet for the treatment of glioblastoma multiforme (2013). In 2021, he began collaborating with Dr. Pravat Mandal on research utilizing magnetic resonance spectroscopy to assess glutathione deficiency—the brain's most abundant antioxidant—as a potential biomarker for the early diagnosis of Alzheimer's and Parkinson's diseases. In 2023, he was appointed to the board of directors of Syncromune, a biotechnology company developing novel immunotherapies that integrate cryosurgery and checkpoint inhibitor drugs for the treatment of solid tumors. In 2025, he and his colleagues received a research grant from the Chuck Noll Foundation to investigate glutathione deficiency in the brains of former National Football League (NFL) players and former Navy SEALs. Dr. Maroon is also an advocate for the use of hyperbaric oxygen therapy in the treatment of post-concussion syndrome, post-traumatic stress disorder (PTSD), long COVID, stroke, and spinal cord injury. He has authored several publications on these topics.
=== Prohibitions and restrictions === Many markets refuse to list weapons or poisons. Markets such as the original Silk Road would refuse to list anything where the "purpose is to harm or defraud, such as stolen credit cards, assassinations, and weapons of mass destruction". Later markets such as Evolution ban "child pornography, services related to murder/assassination/terrorism, prostitution, Ponzi schemes, and lotteries", but allow the wholesaling of credit card data. The market in firearms appears to attract extra attention from law enforcement, as does the selling of other weapons such as certain types of knives and blades.
Sources: en.wikipedia.org
=== Tang and Song Dynasties === Material from the Tang and Song dynastyies (C. 618–1279 A.D) has also been excavated and analysed using ceramic petrography, revealing a plethora of information on trade links, as well as stylistic elements. The Tang dynasty in Shanghai is well-known for its three-colour pottery and its bright colours. After analysing the remains of these artefacts, scientists have been able to trace trade over time, and can now see that maritime trade was only established later on in its history. Qinglong town, the heart of the dynasty was a prosperous maritime economy, with extensive links to adjacent islands. Indeed, through analyses of pottery from Qinglong and surrounding areas, archaeologists have discovered that the Tang and Song Dynasties had trade links with Persians, Arabs, Hindu Indians, Malays, Bengalis, Sinhalese, Khmers, Chams, Jews and Nestorian Christians of the Near East - a vast trade network that helps to explain the wide array of colours and materials in their ceramics.
It is unclear that cyproheptadine achieves adequate serotonin 5-HT2A receptor occupancy at the assessed doses. Further complicating the picture, high doses of cyproheptadine have been reported to produce partial LSD-like discriminative stimulus effects in animals.
6 December Scientists provide a mechanistic biological explanation for why upper respiratory tract infections are more prevalent in the cold or winter season, previously largely explained only by behavioral and environmental variations. They found cold exposure impairs extracellular vesicle (EV) swarm–mediated antiviral immunity in the nose – fewer EVs are secreted and they become less effective. Impossible Metals announces its first underwater robotic vehicle, 'Eureka 1', has completed its first trial of selectively harvesting polymetallic nodule rocks from the seabed nearly without harming the environment (as with other seabed mining) to help address the rising global need for metals for renewable energy system components, mainly batteries. Researchers propose "significantly increasing freshwater through the capture of humid air over oceans" to address present and, especially, future water scarcity/insecurity. Emulate researchers assess advantages of using liver-chips predicting drug-induced liver injury which could reduce the high costs and time needed in drug development workflows/pipelines, sometimes described as the pharmaceutical industry's "productivity crisis". 7 December Scientists report that two-million years old genetic material was found in Greenland, and is currently considered the oldest DNA discovered so far. Scientists propose a new supergroup of eukaryotes, termed Provora – predators of other microorganisms which have been overlooked due to numerical rarity.
=== Chemical labeling === Chemical labeling or the use of chemical tags utilizes the interaction between a small molecule and a specific genetic amino acid sequence. Chemical labeling is sometimes used as an alternative for GFP. Synthetic proteins that function as fluorescent probes are smaller than GFP's, and therefore can function as probes in a wider variety of situations. Moreover, they offer a wider range of colors and photochemical properties. With recent advancements in chemical labeling, Chemical tags are preferred over fluorescent proteins due to the architectural and size limitations of the fluorescent protein's characteristic β-barrel. Alterations of fluorescent proteins would lead to loss of fluorescent properties.
Sources: en.wikipedia.org
== Venom and apitherapy == The main component of bee venom responsible for pain in vertebrates is the toxin melittin; histamine and other biogenic amines may also contribute to pain and itching. In one of the alternative medical uses of honey bee products, apitherapy, bee venom has been used to treat arthritis and other painful conditions. All currently available evidence supporting this practice is either anecdotal, animal studies, or preliminary evidence, most of which has poor methodology. Apitherapy is not currently accepted as a viable medical treatment for any condition or disease; the risk of allergic reaction and anaphylaxis outweighs any benefits. According to the American Cancer Society, there is no scientific evidence that apitherapy or bee venom therapy can treat or change the course of cancer or any other disease. Clinical trials have shown that apitherapy is ineffective in treating multiple sclerosis or any other disease, and can exacerbate multiple sclerosis symptoms.
Following the deaths of children in China from powdered milk in 2008, the Joint Research Centre (JRC) of the European Commission in Belgium set up a website about methods to detect melamine. In May 2009, the JRC published the results of a study that benchmarked the ability of labs around the world to accurately measure melamine in food. The study concluded that the majority of labs can effectively detect melamine in food. In October 2008, the U.S. Food and Drug Administration (FDA) issued new methods for the analysis of melamine and cyanuric acid in infant formulations in the Laboratory Information Bulletin No 4421. Similar recommendations have been issued by other authorities, like the Japanese Ministry of Health, Labor and Welfare, both based on liquid chromatography – mass spectrometry (LC/MS) detection after hydrophilic interaction liquid chromatography (HILIC) separation. The existing methods for melamine determination using a triple quadrupole liquid chromatography – mass spectrometry (LC/MS) after solid phase extraction (SPE) are often complex and time-consuming. However, electrospray ionization methods coupled with mass spectrometry allow a rapid and direct analysis of samples with complex matrices: the native liquid samples are directly ionized under ambient conditions in their original solution. In December 2008, two new fast and inexpensive methods for detecting melamine in liquids have been published.
=== Toxicity === Ingesting less than 1.5 g (1⁄16 oz) of saffron is not toxic for humans, but doses greater than 5 g (3⁄16 oz) can become increasingly toxic. Mild toxicity includes dizziness, nausea, vomiting, and diarrhea, whereas at higher doses there can be reduced platelet count and spontaneous bleeding.
Sources: en.wikipedia.org
It is a synthetic cyclic heptapeptide and an analogue of alpha-melanocyte-stimulating hormone. The molecule is produced by chemical synthesis rather than extracted from a biological source.
It is shorter than the native hormone and carries a cyclic constraint that improves stability. These changes raise receptor potency and slow breakdown relative to the naturally occurring peptide.
Published accounts date its development to the 1980s, when researchers were generating analogues of melanocyte-stimulating hormone. That work aimed to produce more stable compounds for studying pigmentation biology.
It is a synthetic cyclic peptide designed as an analog of alpha-melanocyte-stimulating hormone. It acts on melanocortin receptors and is best known from research into pigmentation. It is not an approved pharmaceutical product.